Selected data models

You must log in to select data models for download or further analysis.

20 Search results.
Relevance Rating New first Old first

Renal Replacement Therapy RICH study NCT02669589

- 6/27/16 - 1 form, 4 itemgroups, 36 items, 1 language
Itemgroups: Patient Information, Dialysis information, Dialysis flow, Catheter: Adjustment
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Visit documentation RICH study NCT02669589

- 6/27/16 - 1 form, 12 itemgroups, 139 items, 1 language
Itemgroups: Patient Information, Documentation period, Adverse Event, Glasgow Coma Scale, Mechanical ventilation, Catecholamine and inotropic therapy, Clinical Data, Concomitant medication, Laboratory Parameters and Blood Gas Analysis, Fluid balance, Transfusion, Microbiology
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Visit documentation: Day 1-14; Day 21+28 Study Chair: Alexander Zarbock, MD University Hospital Muenster

SAE Form RICH study NCT02669589

- 9/20/21 - 1 form, 9 itemgroups, 51 items, 1 language
Itemgroups: Patient Information, Seriousness criteria, Serious Adverse Event (SAE), Treatment of SAE, Drugs, Relevant Medical History, Tests and procedures, Comments, Investigator
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Protocol violation RICH study NCT02669589

- 7/8/16 - 1 form, 3 itemgroups, 14 items, 1 language
Itemgroups: Patient Information, Protocol violation, Identification and Signature
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Adverse Event: Citrate RICH study NCT02669589 - Adverse Event: Citrat RICH study NCT02669589

- 7/8/16 - 1 form, 6 itemgroups, 21 items, 1 language
Itemgroups: Patient Information, Adverse Event Description, Duration, Therapy, Comments, Case report form data
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Adverse Event: Heparin RICH study NCT02669589

- 7/8/16 - 1 form, 6 itemgroups, 21 items, 1 language
Itemgroups: Patient Information, Adverse Event Description, Duration, Therapy, Comments, Case report form data
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Pre-Screening Log RICH study NCT02669589

- 7/8/16 - 1 form, 3 itemgroups, 9 items, 1 language
Itemgroups: Patient Information, Inclusion Criteria, Reason for Exclusion
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

End of Therapy RICH study NCT02669589

- 7/1/16 - 1 form, 4 itemgroups, 17 items, 1 language
Itemgroups: Patient Information, End of Therapy, End of documentation, Hospital stay
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Consent RICH study NCT02669589

- 7/4/16 - 1 form, 3 itemgroups, 16 items, 1 language
Itemgroups: Patient Information, Subsequent consent, Withdrawal of consent
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Follow Up RICH study NCT02669589

- 7/2/16 - 1 form, 3 itemgroups, 16 items, 1 language
Itemgroups: Patient Information, Folllow Up, Renal Replacement Therapy
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

ICU - Hospital Stay RICH study NCT02669589

- 7/4/16 - 1 form, 3 itemgroups, 14 items, 1 language
Itemgroups: Patient Information, Discharge Date, Further Hospital Stays
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

RRT Agents RICH study NCT02669589

- 7/1/16 - 1 form, 3 itemgroups, 20 items, 1 language
Itemgroups: Patient Information, Early Renal Replacement Therapy Agents, Late Renal Replacement Therapy Agents
NCT02669589 EudraCT-Nr. 2014-004854-33 REGIONAL CITRATE VERSUS SYSTEMIC HEPARIN ANTICOAGULATION FOR CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Study Chair: Alexander Zarbock, MD University Hospital Muenster

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial